Oaktree Specialty Stock Price, News & Analysis

Oaktree Specialty Lending Corporation (NASDAQ: OCSL) reported its Q2 2025 financial results, showing significant declines across key metrics. Total investment income decreased to $77.6M ($0.90 per share) from $86.6M ($1.05 per share) in Q1 2025, primarily due to a smaller investment portfolio and non-accrual investments. Net asset value (NAV) per share fell to $16.75 from $17.63 in the previous quarter. The company originated $407.0M in new investment commitments with a 9.5% weighted average yield on new debt investments. Notable transactions included a $100M share purchase by Oaktree Capital I at NAV and issuance of $300M in unsecured notes. The Board declared a quarterly distribution of $0.40 per share plus a $0.02 supplemental distribution, payable June 30, 2025. Non-accrual investments increased to 4.6% of debt investments at fair value, up from 3.9% in the previous quarter.

Oaktree Specialty Lending (NASDAQ:OCSL) has announced significant amendments to its senior secured revolving credit facility. The key changes include extending the maturity date from June 2028 to April 2030 and reducing the interest rate from SOFR plus 2.00% to SOFR plus 1.75% to 1.875%, depending on debt outstanding, plus a 0.10% SOFR adjustment.

The amended facility maintains its accordion feature, allowing OCSL to potentially increase the facility size to $1,500 million under certain conditions. Additionally, the minimum consolidated interest coverage ratio requirement of 2.25x has been removed. The current interest rate stands at SOFR plus 1.875%, plus the 0.10% SOFR adjustment.

Oaktree Specialty Lending (NASDAQ:OCSL) has scheduled its second fiscal quarter earnings conference call for May 1, 2025. The company will release its financial results for the quarter ended March 31, 2025, before the Nasdaq Global Select Market opens.

The conference call will be held at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time. Investors can access the call by dialing (877) 507-3275 (U.S.) or +1 (412) 317-5238 (non-U.S.), referencing 'Oaktree Specialty Lending'. Alternatively, a live webcast will be available through the Investors section of the company's website. A replay will be accessible via the website or by phone using access code 3296634.

Oaktree Specialty Lending (NASDAQ: OCSL) has announced the pricing of a $300 million public offering of 6.340% notes due 2030. The notes will mature on February 27, 2030, with an option for early redemption at par plus a 'make-whole' premium. The company plans to use the net proceeds to reduce outstanding debt under its revolving credit facilities and for general corporate purposes.

The offering, expected to close on February 27, 2025, is being managed by multiple financial institutions, with SMBC Nikko Securities America, BNP Paribas Securities, ING Financial Markets, and Wells Fargo Securities acting as joint book-running managers. Several other firms are participating as co-managers in this offering.

Oaktree Specialty Lending (NASDAQ: OCSL) reported its financial results for Q1 FY2025. Key highlights include:

Oaktree Capital purchased $100 million of OCSL shares at $17.63 per share (NAV as of January 31, 2025), representing a 10% premium to market price. Total investment income was $86.6 million ($1.05 per share), down from $94.7 million in Q4 2024. GAAP net investment income was $44.3 million ($0.54 per share), slightly lower than $44.9 million ($0.55 per share) in the previous quarter.

The company's NAV per share decreased to $17.63 from $18.09, primarily due to losses on debt and equity investments. The company originated $198.1 million in new investments while receiving $352.4 million from prepayments and exits. The Board declared a quarterly distribution of $0.40 per share plus a supplemental distribution of $0.07 per share, payable March 31, 2025.

Oaktree Specialty Lending (NASDAQ:OCSL) has scheduled its first fiscal quarter earnings conference call for February 4, 2025. The company will release its financial results for the quarter ended December 31, 2024, before the Nasdaq Global Select Market opens.

The conference call will take place at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time. Investors can access the call by dialing (877) 507-3275 (U.S.) or +1 (412) 317-5238 (non-U.S.), referencing 'Oaktree Specialty Lending'. Alternatively, a live webcast will be available through the Investors section of the company's website. A replay will be accessible via the website or by phone using access code 4539816.

Oaktree Specialty Lending reported its Q4 and full year 2024 financial results. Total investment income was $94.7M ($1.15/share) for Q4 and $381.7M ($4.75/share) for the full year. Net investment income was $44.9M ($0.55/share) for Q4 and $175.1M ($2.18/share) for the full year. The company's NAV per share decreased to $18.09 as of September 30, 2024, down from $18.19 in Q3 and $19.63 year-over-year. The company originated $259M in new investment commitments during Q4. The Board declared a quarterly distribution of $0.55 per share, payable December 31, 2024.

Oaktree Specialty Lending (NASDAQ:OCSL) has announced its schedule for the fourth fiscal quarter and full year 2024 earnings conference call, set for November 19, 2024. The company will report its financial results before the Nasdaq Global Select Market opens on that day. Management will host a conference call at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time to discuss the results.

Investors can access the call by dialing (877) 507-3275 (U.S. callers) or +1 (412) 317-5238 (non-U.S. callers) and referencing "Oaktree Specialty Lending". Alternatively, a live webcast will be available through the Investors section of the company's website. A replay of the call will be accessible on the website or by phone using the provided numbers and access code 1211943.

Oaktree Specialty Lending (NASDAQ: OCSL) announced its financial results for the fiscal quarter ended June 30, 2024. Total investment income was $95.0 million ($1.16 per share), a slight increase from $94.0 million ($1.18 per share) in the prior quarter, driven by higher interest income and OID accretion, but offset by non-accrual investments and lower amendment fees.

Adjusted total investment income was $95.6 million ($1.17 per share), down from $97.3 million ($1.22 per share). GAAP net investment income rose to $44.6 million ($0.54 per share) from $41.4 million ($0.52 per share). However, NAV per share decreased to $18.19 from $18.72, due to unrealized losses.

New investment commitments were $338.7 million with proceeds of $185.5 million from prepayments and sales. The quarterly distribution of $0.55 per share is payable on September 30, 2024, to stockholders of record on September 16, 2024.